2025-04-29
Realheart Receives Patent Approval in Japan
Västerås, Sweden, April 29, 2025 – Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor device for artificial hearts and circulatory support systems such as Realheart® TAH. The patent is a supportive measure to ensure market protection of the company’s device on the Japanese market and is valid until 2041.
Realheart develops Realheart® TAH, the world’s first total artificial heart mimicking the shape, function, and blood flow pattern of the human heart. The patent (JP7656624B2) covers a pressure sensor with a biocompatible housing with integrated pressure-sensitive components used in the device. The sensor is designed to ensure accurate and safe pressure measurements in medical environments. By enabling real-time monitoring, the sensor supports automated control of artificial hearts and circulatory support systems, such as Realheart® TAH, contributes to optimized blood flow and has a potential positive effect on treatment outcomes. The design is engineered for integration into advanced medical systems, particularly within the field of artificial hearts and circulatory support.
The granted patent confers protection for the device in Japan until 2041.